Graded alterations of RBC aggregation influence in vivo blood flow resistance.
Although the effects of red blood cell (RBC) aggregation on low-shear rate blood viscosity are well known, the effects on in vivo flow resistance are still not fully resolved. The present study was designed to explore the in vivo effects of RBC aggregation on flow resistance using a novel technique to enhance aggregation: cells are covalently coated with a block copolymer (Pluronic F-98) and then suspended in unaltered plasma. RBC aggregation was increased in graded steps by varying the Pluronic concentration during cell coating and was verified by microscopy and erythrocyte sedimentation rate (ESR), which increased by 200% at the highest Pluronic level. RBC suspensions were perfused through an isolated in situ guinea pig hindlimb preparation while the arterial perfusion pressure was held constant at 100 mmHg via a pressure servo-controlled pump. No significant effects of enhanced RBC aggregation were observed when studies were conducted in preparations with intact vascular control mechanisms. However, after inhibition of smooth muscle tone (using 10(-4) M papaverin), a significant change in flow resistance was observed in a RBC suspension with a 97% increase of ESR. Additional enhancements of RBC aggregation (i.e., 136 and 162% increases of ESR) decreased flow resistance almost to control values. This was followed by another significant increase in flow resistance during perfusion with RBC suspensions with a 200% increase of ESR. This triphasic effect of graded increases of RBC aggregation is most likely explained by an interplay of several hemodynamic mechanisms that are triggered by enhanced RBC aggregation.
Yalcin
Ozlem
O
Dept. of Physiology, Akdeniz Univ. Faculty of Medicine, Kampus, 07058 Antalya, Turkey.
Uyuklu
Murat
M
Armstrong
Jonathan K
JK
Meiselman
Herbert J
HJ
Baskurt
Oguz K
OK
D000818:Animals; D001799:Blood Sedimentation; D002449:Cell Aggregation / Q000187:drug effects / Q000502:physiology; D004912:Erythrocytes / Q000166:cytology* / Q000502:physiology*; D005260:Female; D006168:Guinea Pigs; D006614:Hindlimb; D008297:Male; D010477:Perfusion; D020442:Poloxamer / Q000494:pharmacology; D014655:Vascular Resistance / Q000502:physiology*
D020442:Poloxamer